Affiliation:
1. Department of Emergency Medicine, Health Science University, Antalya Training and Research Hospital, Antalya, Turkey
Abstract
Ticagrelor is available as an oral antiplatelet agent that can bind reversibly to the adenosine diphosphate receptor P2Y12 on platelets without first having to be activated. Main side effects such as dizziness, bleeding gums, nausea in common, difficulty in speaking, fever, and change in mental status are rare. Herein, we report a patient who had seizures after the usage of ticagrelor.
Subject
Ocean Engineering,Safety, Risk, Reliability and Quality